Dynavax Technologies Corp (NASDAQ:DVAX)
| 11.18 Delayed Data As of May 19 |  +1.56 / +16.22%Today’s Change | 7.26 Today|||52-Week Range 21.39 | -20.54% Year-to-Date |
Latest DVAX News | Press Releases
| Why Dynavax Stock Blasted 16% Higher Today May 19 / MotleyFool.com - Paid Partner Content | Why Dynavax Stock Won on a Losing Monday for the Market May 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.62 |
| Today’s open | 9.62 |
| Day’s range | 9.62 - 11.26 |
| Volume | 267,040 |
| Average volume (3 months) | 2,317,132 |
| Market cap | $1.2B |
Data as of 4:03pm ET, 05/19/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +124.21% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +838.85% |
| P/E ratio | 14.3 |
| Price/Sales | 4.28 |
| Price/Book | 5.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AXSMAxsome Therapeutics ... | +0.40 | +1.28% |
| PRTAProthena Corporation... | +0.68 | +2.66% |
| SRRASierra Oncology Inc | +0.06 | +0.11% |
| XNCRXencor Inc | +0.45 | +2.00% |
Data as of 4:03pm ET, 05/19/2022
Financials
| Next reporting date | August 10, 2022 |
| EPS forecast (this quarter) | $0.29 |
| Annual revenue (last year) | $437.0M |
| Annual profit (last year) | $72.1M |
| Net profit margin | 16.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
